Barbara J. Gitlitz

8.5k citations
121 papers · 4.8k · 2 hit papers · h-index 37

Impact in

Papers in

    • Lung Cancer Treatments and Mutations 33
    • Renal cell carcinoma treatment 17
    • Cancer Immunotherapy and Biomarkers 19
    • Lung Cancer Research Studies 11
    • CAR-T cell therapy research 10
    • Colorectal Cancer Treatments and Studies 8

Barbara J. Gitlitz

118 papers receiving 4.6k citations

Barbara J. Gitlitz's Hit Papers

Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer 2010 · 366 citations
3660+8+16Years since publication100200300400500

Peers

Barbara J. Gitlitz
Comparison fields: 5 of 102
  • Pulmonary and Respiratory Medicine 2.6k
  • Oncology 1.6k
  • Cancer Research 688
  • Molecular Biology 1.8k
  • Immunology 469
Replace Noemı́ Reguart with:
Noemı́ Reguart Spain
Przemyslaw Twardowski United States
Makoto Maemondo Japan
Roberto Iacovelli Italy
Hiroshi Nokihara Japan
Simon Ekman Sweden
Hidetoshi Hayashi Japan
Manuel Cobo Spain
Samuel E. DePrimo United States
Carolyn D. Britten United States
Barbara J. Gitlitz relative to Noemı́ Reguart Spain Noemı́ Reguart's profile →
Citations per field
00.5×1.5×
Noemı́ Reguart · 1×
Citations per year

Countries citing papers authored by Barbara J. Gitlitz

Since Specialization
Citations

This map shows the geographic impact of Barbara J. Gitlitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara J. Gitlitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara J. Gitlitz more than expected).

Fields of papers citing papers by Barbara J. Gitlitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara J. Gitlitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara J. Gitlitz. The network helps show where Barbara J. Gitlitz may publish in the future.

Co-authors

The 25 scholars most cited alongside Barbara J. Gitlitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara J. Gitlitz Line = papers co-authored together Barbara J. Gitlitz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System
Hit paper breakdown →
2001574
2
Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer
Hit paper breakdown →
2010366
3 2009238
4 2003210
5 2003144
6 2009140
7 2003139
8 2018138
9 1997136
10 2013122
11 2001115
12
Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
2001113
13 2011111
14 2003102
15 200296
16 200293
17 200377
18 201174
19 201173
20 201673

About Barbara J. Gitlitz

Barbara J. Gitlitz is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Surgery and Immunology, having authored 121 papers that have together received 4.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (33 papers), Cancer Immunotherapy and Biomarkers (19 papers), Renal cell carcinoma treatment (17 papers), Immunotherapy and Immune Responses (12 papers), Lung Cancer Research Studies (11 papers), CAR-T cell therapy research (10 papers), Colorectal Cancer Treatments and Studies (8 papers) and Bladder and Urothelial Cancer Treatments (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.6k citations), Oncology (1.6k citations), Cancer Research (688 citations), Molecular Biology (1.8k citations) and Immunology (469 citations). Barbara J. Gitlitz has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Robert A. Figlin, Arie S. Belldegrun, Allan J. Pantuck, Amnon Zisman, Jonathan Said, Fredrick Dorey, Jean B. deKernion, Debby H. Chao, David R. Gandara and Oleg Shvarts. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, The Journal of Urology, Annals of Oncology and Journal of Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact